North Granby, CT, United States of America

Richard Pfeifer

USPTO Granted Patents = 9 

 

 

Average Co-Inventor Count = 9.6

ph-index = 5

Forward Citations = 55(Granted Patents)


Company Filing History:


Years Active: 2016-2025

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Richard Pfeifer: Innovator in CNS Therapy

Introduction

Richard Pfeifer, a notable inventor based in North Granby, Connecticut, has made significant strides in the field of central nervous system (CNS) therapies. With a remarkable portfolio of 8 patents, his work addresses critical challenges in treating lysosomal storage diseases, particularly through innovative methods and formulations.

Latest Patents

Among Richard's latest patents is the invention titled "Methods and Compositions for CNS Delivery of Heparan N-sulfatase." This invention presents compositions and methods for delivering lysosomal enzymes effectively to the CNS, thereby offering potential treatments for lysosomal storage diseases such as Sanfilippo Syndrome Type A. His other notable patent, "CNS Delivery of Therapeutic Agents," introduces a less invasive method for direct delivery of therapeutic agents to the CNS. This invention emphasizes intrathecal administration of replacement enzymes to treat conditions associated with lysosomal enzyme deficiencies.

Career Highlights

Throughout his career, Richard has collaborated with major pharmaceutical companies, including Shire Human Genetic Therapies and Takeda Pharmaceutical Company Limited. His expertise and innovative approach have influenced the development of therapies that aim to improve the lives of patients affected by serious genetic conditions.

Collaborations

Richard has worked closely with esteemed colleagues such as Jing Pan and Pericles Calias, who have shared in the innovative endeavors aimed at advancing CNS therapies. Their collaborative efforts have significantly contributed to the success of the projects they have undertaken, particularly in the realm of lysosomal storage diseases.

Conclusion

Richard Pfeifer's contributions to the field of CNS therapy are marked by his dedication to innovation and his commitment to improving patient outcomes. With a solid track record of patents and collaborations, he continues to be a key figure in the ongoing development of effective treatments for lysosomal storage diseases, driven by a vision to enhance the quality of life for those affected.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…